1,414 results on '"Lanctôt, Krista L."'
Search Results
2. Burden of Illness in People with Alzheimer’s Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality
3. Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in Stroke
4. Heterogeneity of Cognition in Older Adults with Remitted Major Depressive Disorder: A Latent Profile Analysis
5. The effect of exercise on blood concentrations of angiogenesis markers in older adults: A systematic review and meta-analysis
6. Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 Trial
7. Novel fluid biomarkers for mild cognitive impairment: A systematic review and meta-analysis
8. Engaging Mood Brain Circuits with Psilocybin (EMBRACE): a study protocol for a randomized, placebo-controlled and delayed-start, neuroimaging trial in depression
9. Cognitive function based on theta-gamma coupling vs. clinical diagnosis in older adults with mild cognitive impairment with or without major depressive disorder
10. Relationships of change in Clinical Dementia Rating (CDR) on patient outcomes and probability of progression: observational analysis
11. Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial)
12. Cytochrome P450-soluble epoxide hydrolase derived linoleic acid oxylipins and cognitive performance in type 2 diabetes
13. Cognitive control, interference inhibition, and ordering of information during working memory in younger and older healthy adults
14. Identifying factors influencing cognitive outcomes after anodal transcranial direct current stimulation in older adults with and without cognitive impairment: A systematic review
15. Revisiting Criteria for Psychosis in Alzheimer's Disease and Related Dementias: Toward Better Phenotypic Classification and Biomarker Research.
16. Sex‐specific neuropsychological correlates of apathy and depression across neurodegenerative disorders
17. Investigating the impact of hypertension with and without diabetes on Alzheimer's disease risk: A clinico‐pathological study
18. Altered central and blood glutathione in Alzheimer’s disease and mild cognitive impairment: a meta-analysis
19. Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis
20. Pharmacological Management of Apathy in Dementia
21. Medical Cannabis Use Among Older Adults in Canada: Self-Reported Data on Types and Amount Used, and Perceived Effects
22. Perspectives on ethnic and racial disparities in Alzheimer's disease and related dementias: Update and areas of immediate need.
23. Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis
24. Blood-based biomarkers of agitation in Alzheimer's disease: Advances and future prospects
25. Depression in type 2 diabetes: A systematic review and meta-analysis of blood inflammatory markers
26. Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms
27. Association between clinical dementia rating and clinical outcomes in Alzheimer's disease
28. Depression and Increased Risk of Alzheimer's Dementia: Longitudinal Analyses of Modifiable Risk and Sex-Related Factors
29. Reduction of agitation and caregiver distress using a combination intervention of tetrahydrocannabinol and melatonin in dementia due to Alzheimer disease
30. Changes in Brain Glutathione in patients with mild vascular cognitive impairment
31. Investigating the effects of aerobic exercise primed anodal transcranial direct current stimulation on γ‐aminobutyric acid concentrations in mild vascular cognitive impairment
32. Beta to Theta Power Ratio in Electroencephalogram Periodic Components to Discriminate Mild Cognitive Impairment and Alzheimer’s Dementia
33. Characterizing PRN Use of Psychotropic Medications for Acute Agitation in Canadian LTC Residents With Dementia Before and During COVID‐19
34. Brain glutathione may be associated with white matter hyperintensities in patients with cardiovascular disease
35. Fluid Biomarkers of Neurodegeneration in Mild Cognitive Impairment: A Meta‐Analysis
36. Reduction of neuropsychiatric symptoms and associated caregiver distress using a tetrahydrocannabinol and melatonin combination in dementia due to Alzheimer’s disease
37. Changing the trajectory of Alzheimer’s disease: What is a meaningful delay in disease progression?
38. Investigating the impact of hypertension with and without diabetes on progression to Alzheimer’s disease: A clinic‐pathological study
39. Effect of tetrahydrocannabinol and melatonin combination on suicide ideation and behavior in dementia due to Alzheimer’s disease
40. Risk of motor vehicle collisions and culpability among older drivers using cannabis: a meta‐analysis
41. Profiles of modifiable dementia risk factors in later midlife: a latent class analysis
42. Reduction of apathy and caregiver distress using a combination of tetrahydrocannabinol and melatonin in dementia due to Alzheimer’s disease
43. Associations between homocysteine, tau, and neurodegenerative markers in apolipoprotein ε4 non‐carriers with clinical Alzheimer’s disease
44. Mapping of validated apathy scales onto the apathy diagnostic criteria for neurocognitive disorders
45. Effect of the combination of tetrahydrocannabinol and melatonin (IGC‐AD1) on blood pressure variability in patients with mild to moderate Alzheimer’s Disease
46. Blood‐based biomarkers for predicting treatment response in the Apathy in Dementia Methylphenidate Trial 2 randomized clinical trial
47. Circulating cell‐free mitochondrial DNA (ccf‐mtDNA) and memory in mild cognitive impairment (MCI) and Alzheimer’s disease (AD)
48. Association between lipopolysaccharide, immune biomarkers and cerebral amyloid‐beta deposition in older adults with mild cognitive impairment & major depressive disorder
49. A Literature Review on the Burden of Alzheimer’s Disease on Care Partners
50. Serum soluble epoxide hydrolase related oxylipins and major depression in patients with type 2 diabetes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.